--- title: "Carbios shareholders adopt all AGM resolutions with over 87% support" type: "News" locale: "en" url: "https://longbridge.com/en/news/290388742.md" description: "Carbios shareholders approved all resolutions at the June 18, 2026 AGM with over 87% support. The meeting featured an update on the Kaibio joint venture with Wankai for a PET biorecycling plant in China. While Kaibio is tasked with future construction and operations, the disclosure did not confirm that building or operations have commenced." datetime: "2026-06-22T05:48:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/290388742.md) - [en](https://longbridge.com/en/news/290388742.md) - [zh-HK](https://longbridge.com/zh-HK/news/290388742.md) generator: "portal-rs" --- # Carbios shareholders adopt all AGM resolutions with over 87% support - Carbios’ shareholders met June 18, 2026 for the annual and extraordinary general meeting. \* All agenda resolutions were adopted. \* The meeting included an update on the Kaibio joint venture with Wankai to build and run a PET biorecycling plant in China under license. \* The disclosure did not confirm construction or operations have started; it described Kaibio as responsible for future build-out and operation. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carbios SA published the original content used to generate this news brief on June 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [301216.CN](https://longbridge.com/en/quote/301216.CN.md) ## Related News & Research - [Carbios forms Kaibio JV with Wankai for first PET biorecycling plant in China](https://longbridge.com/en/news/290388408.md) - [Grey Matters Health signs ProScan to read brain PET scans for Florida NovaScan clinic](https://longbridge.com/en/news/296343901.md) - [CAA: Modest growth in revenue and profit, with acquisitions set to drive stronger H2 results](https://longbridge.com/en/news/296579234.md) - [Revive Therapeutics Outlines Strategy to Build a Biodefence and Pandemic Preparedness Therapeutics Portfolio | RVVTF Stock News](https://longbridge.com/en/news/296357987.md) - [BioNxt completes IMPD, moves toward first human bioequivalence trial for sublingual cladribine film in MS](https://longbridge.com/en/news/296314929.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**